Transition from stem cell to adenoma is accompanied by several somatic mutations, typically involving complete mutational inactivation of the Adenomatous Polyposis Coli (APC) tumor suppressor gene [1] or mutations disrupting β-catenin function [2]. This evidence concerns the gene APC and adenoma.